The Indian pharmaceutical sector showed mixed performance on February 10, 2026, as of around 10:05 AM IST. The data provided reflects early trading prices and percentage changes for various pharma stocks listed on BSE and NSE.
Overall Sector Snapshot
- Broader market indices were positive in early trade, with Nifty 50 around 25,954.90 (up 0.34%) and BSE Sensex around 84,376.90 (up 0.37%).
- Pharma stocks displayed varied movements, with several posting gains in the 1-5% range, while some declined.
- Notable strong performers included Pfizer (up approximately 9% on both exchanges), GSK Pharma (up around 4%), IOL Chemicals & Pharm. (up around 5%), Jeena Sikho (up around 4.4%), and Hikal (up around 4%).
- On the downside, stocks like Jubilant Industries (down around 4%), Zydus Lifesciences (down around 2.5-2.7%), and Wyeth showed notable declines (with one outlier figure likely a data error).
- Other key names like Sun Pharma, Cipla, Divis Laboratories, Torrent Pharma, and Lupin traded with modest gains in the 0.6-1.5% range.
Top Gainers (Based on Provided Data, Early Session)
- Pfizer: BSE 5,191.00 (+9.04%), NSE 5,199.00 (+9.13%)
- GSK Pharma: BSE 2,622.10 (+4.42%), NSE 2,619.90 (+4.12%)
- Jeena Sikho: 775.00 (+4.45%)
- IOL Chemicals & Pharm.: 82.47 (+4.94%)
- Hikal: 191.85 (+4.01%)
- Shukra Pharma: 46.79 (+4.98%)
- Solara Active Pharma Sciences: 495.20 (+3.51%)
- Healthcare Global Enter.: 577.90 (+3.06%)
Notable Movers and Others
- Divis Laboratories: Around 6,206.10 (+1.47%)
- Cipla: Around 1,356.20 (+1.02%)
- Lupin: Around 2,223.85 (+1.13%)
- Aurobindo Pharma: Around 1,204.90 (+0.30%)
- Sun Pharma: Around 1,715.75 (+0.65%)
- Biocon: 372.00 (-0.51%)
- Zydus Lifesciences: 899.40 (-2.57%)
- Dr. Reddys Lab: 1,270.00 (-0.38%)
Note that these are early-session figures (as of ~10:05 AM IST on February 10, 2026), and prices can fluctuate throughout the trading day.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.